During the past decade, Sanatorio Duarte Quiroz conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanatorio Duarte Quiroz" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Nektar Therapeutics" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanatorio Duarte Quiroz" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "ARTTIC International Management Services" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Federación Argentina de Cardiología FAC" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Sanatorio Duarte Quiroz" are "Cardiovascular Disease" (2 trials), "Colitis, Ulcerative" (2 trials), "Acute Respiratory Infection" (1 trials), "COVID-19" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Sanatorio Duarte Quiroz" in a lesser frequency.

Most popular intervention types in "Sanatorio Duarte Quiroz" are "Drug" (13 trials), "Biological" (5 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Guselkumab" (3 trials), "Golimumab" (2 trials), "JNJ-78934804" (2 trials) and "Nivolumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio Duarte Quiroz" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Sanatorio Duarte Quiroz". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Sanatorio Duarte Quiroz, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio Duarte Quiroz, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".